Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders.

The Journal of investigative dermatology - 1 Oct 2020

Maurus Katja, Appenzeller Silke, Roth Sabine, Brändlein Stephanie, Kneitz Hermann, Goebeler Matthias, Rosenwald Andreas, Geissinger Eva, Wobser Marion

Abstract excerpt

The group of cutaneous CD30-positive lymphoproliferative disorders (LPD) comprises two different entities, namely lymphomatoid papulosis (LyP) and cutaneous anaplastic large T-cell lymphoma (cALCL). LyP constitutes a benign lymphoproliferation with spontaneously regressing papules, whereas cALCL presents with solitary or multiple skin tumors with a low propensity to disseminate. To elucidate the hitherto largely...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Fusion
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinases

Share to Ki-1 Antigen

Share to Lymphoma, T-Cell, Cutaneous

Share to Proto-Oncogene Proteins p21(ras)

Share to Skin Neoplasms

Share to STAT Transcription Factors

Source

Identifiers

PMID: 32147503
DOI: 10.1016/j.jid.2020.02.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders.PMID 32147503Read ↗

Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same PatientsSemantic proximity Read ↗

Updates in pathobiological aspects of anaplastic large cell lymphomaSemantic proximity Read ↗

A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.Semantic proximity Read ↗

Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphomaSemantic proximity Read ↗

Whole-genome profiling of primary cutaneous anaplastic large cell lymphomaSemantic proximity Read ↗

Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.Semantic proximity Read ↗

Genetics Abnormalities with Clinical Impact in Primary Cutaneous LymphomasSemantic proximity Read ↗

Genetic and epigenetic insights into cutaneous T-cell lymphomaSemantic proximity Read ↗

Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.Semantic proximity Read ↗

Primary Cutaneous CD30 positive Lymphoproliferative Disorders—Current Therapeutic Approach with Focus on Brentuximab VedotinSemantic proximity Read ↗

Anaplastic Large Cell LymphomasSemantic proximity Read ↗

Molecular pathogenesis of cutaneous lymphoma-Future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.